PCSA - Processa Pharmaceuticals, Inc.
2.8
0.260 9.286%
Share volume: 87,925
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$2.54
0.26
0.10%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-13-2024 | 10-30-2024 | 03-20-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | |
| Cash flow financing | 6.263 M | -3.414 K | 926.196 K | 547.582 K | 4.436 M | 6.310 M | 2.856 M | |
| Other financing cash flows | -19.380 K | -3.414 K | -5.095 K | -1.776 K | -2.975 K | -10.279 K | -3.752 K | |
| Cash flow | 4.214 M | 0.000 | -2.680 M | 0.000 | 1.706 M | 0.000 | 0.000 | |
| Net income | -2.726 M | -3.010 M | -3.385 M | -2.729 M | -2.834 M | -3.934 M | -3.437 M | |
| Depreciation | 139.000 | 139.000 | 203.000 | 301.000 | 301.000 | 301.000 | 301.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | -3.244 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 4.214 M | -3.349 M | -2.680 M | -1.700 M | 1.706 M | 4.040 M | -628.200 K |